Tag: fertility

A first-of-its-kind solution for women’s arousal - the same active ingredient as in Viagra^® for men - in a proprietary topical formulation demonstrated to work where women need it most

Burlingame, CA, July 15, 2025 (GLOBE NEWSWIRE) -- The global Vitrification Market is estimated to be valued at USD 10.82 Bn in 2025 and is expected to reach USD 31.15 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 16.3% from 2025 to 2032. The vitrification market is witnessing growing demand due to its expanding applications in biobanking, assisted reproductive technologies, and cryopreservation of oocytes, embryos, and stem cells. This technique offers faster cooling rates and higher cell survival compared to conventional freezing, making it increasingly preferred in fertility clinics and research institutions. Market growth is also driven by advancements in cryoprotectant solutions and rising awareness of fertility preservation. Opportunities lie in emerging markets, technological innovations, and collaborations between biotech firms and healthcare providers to improve storage protocols and expand access to vitrification services.

LAUSANNE, Switzerland and COPENHAGEN, Denmark, July 01, 2025 (GLOBE NEWSWIRE) -- ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced that the first participant has been included in the company’s Phase 2 clinical trial of its lead candidate RPN-001 (leflutrozole), an orally administered aromatase inhibitor in development for the treatment of male infertility (https://clinicaltrials.gov/study/NCT06993155?term=Leflutrozole&rank=1).